Show simple item record

dc.contributor.authorSilva, Marcelo.
dc.contributor.authorArab, Juan.
dc.contributor.authorDirchwolf, Melisa.
dc.contributor.authorEt al.
dc.date.accessioned2023-12-26T14:27:09Z
dc.date.available2023-12-26T14:27:09Z
dc.date.issued2020-11
dc.identifier.citationAnn Hepatol . 2020 Nov-Dec;19(6):674-690.es
dc.identifier.issn2659-5982
dc.identifier.urihttps://riu.austral.edu.ar/handle/123456789/2623
dc.descriptionDisponible en: https://www.sciencedirect.com/science/article/pii/S1665268120301770?via%3Dihubes
dc.description.abstractAbstract Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence is predicted to increase exponentially in the next decades, concomitantly with the global epidemic of obesity, type 2 diabetes mellitus (T2DM), and sedentary lifestyle. NAFLD is a clinical syndrome that encompasses a wide spectrum of associated diseases and hepatic complications such as hepatocellular carcinoma (HCC). Moreover, this disease is believed to become the main indication for liver transplantation in the near future. Since NAFLD management represents a growing challenge for primary care physicians, the Asociación Latinoamericana para el Estudio del Hígado (ALEH) has decided to organize this Practice Guidance for the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease, written by Latin-American specialists in different clinical areas, and destined to general practitioners, internal medicine specialists, endocrinologists, diabetologists, gastroenterologists, and hepatologists. The main purpose of this document is to improve patient care and awareness of NAFLD. The information provided in this guidance may also be useful in assisting stakeholders in the decision-making process related to NAFLD. Since new evidence is constantly emerging on different aspects of the disease, updates to this guideline will be required in future. Keywords: Cirrhosis; Clinical practice guidance; Fatty liver; MAFLD; NAFLD; NASH; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Steatosis. Copyright © 2020. Published by Elsevier España, S.L.U. PubMed Disclaimeres
dc.language.isoenes
dc.publisherElsevieres
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCirrhosises
dc.subjectClinical practice guidancees
dc.subjectFatty liveres
dc.titleLatin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease.es
dc.typeArticlees


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional